期刊文献+

高效液相色谱法测定间尼索地平不同对映体在血浆中的蛋白结合率 被引量:5

Determination of the protein binding rates of m-nisoldipine enantiomers with different genera of plasma by HPLC
原文传递
导出
摘要 目的:建立间尼索地平不同对映体在大鼠血浆、人血浆和牛血清白蛋白中蛋白结合率的测定方法,并计算不同种属血浆蛋白的相关参数。方法:采用平衡透析法测定蛋白结合率,用高效液相色谱法测定血浆中药物总浓度及游离药物浓度。结果:R-与S-间尼索地平的血浆蛋白结合率分别为:大鼠血浆为(97.4±8.2)%、(93.0±13.4)%;人血浆为(90.8±10.5)%、(89.2±9.9)%;牛血清白蛋白为(95.3±8.7)%、(91.0±5.7)%。最低定量下限为0.01ng。结论:在体外间尼索地平不同对映体与大鼠血浆、人血浆和牛血清白蛋白结合率很高,R-间尼索地平的结合率及蛋白结合药物的表观最大能力βp均较S-间尼索地平高。随着药物血浆浓度升高,R-间尼索地平结合率下降,S-间尼索地平结合率升高,均有一定的浓度依赖性。 OBJECTIVE A HPLC method was established to determine the protein binding rates of m-nisoldipine enantiomers in human plasma, rat plasma, bovine serum albumin(BSA), and to calculative the correlate parameters of rn-nisoldipine enantiomers to different genera plasma proteins. METHODS The binding rates of m-nisoldipine enantiomers with different genera plasma proteins were determined by equilibrium dialysis method. The concentrations of m-nisoldipine enantiomers were assayed by HPLC. RESULTS The binding rates of R-, S-m-nisoldipine with rat, human plasma and BSA were (97. 4 ± 8. 2) %, (93.0 ± 13.4) % ; (90. 8 ± 10. 5) %, (89. 2 ±9. 9)% and (95.3± 8. 7) %, (91.0 ±5. 7)%, respectively. The method was sensitive with a lower limit of quantification of 0. 01 ng in different plasma. CONCLUSION The binding rates of m-nisol- dipine enantiomers to human plasma protein, rat plasma protein and BSA were very high. The plasma protein binding rate and of R-m-nisoldipine was higher than those of S-m-nisoldipine. Moreover the binding rate was inversely proportional to plasma concentration of R-rn-nisoldipine, while the S-rn-nisoldipine was identical.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2011年第3期181-185,共5页 Chinese Journal of Hospital Pharmacy
基金 国家自然科学基金项目(编号:30840098) 河北省自然科学基金资助项目(编号:C2008001073)
关键词 间尼索地平 对映体 蛋白结合率 平衡透析法 高效液相色谱法 m-nisoldipine enantiomers plasma protein binding rate equilibrium dialysis method high performance liquid chromatography
  • 相关文献

参考文献6

二级参考文献8

共引文献23

同被引文献37

  • 1武引文,颜廷仁,聂辉,袁凤燕.间尼索地平的合成[J].中国医药工业杂志,1989,20(3):104-106. 被引量:6
  • 2王树华,尚清,张永健.间尼索地平在大鼠体内的组织分布、排泄及血浆蛋白结合率的测定[J].中国医药工业杂志,2006,37(11):752-755. 被引量:9
  • 3杨秀伟,徐波,冉福香,吴军,王瑞卿,崔景荣.40种香豆素类化合物对人胃癌细胞株BGC和人肝癌细胞株BEL-7402细胞生长抑制活性的筛选[J].中国现代中药,2006,8(11):7-9. 被引量:27
  • 4Tanakak T, Kawabata K,Kakumoto M, et al. Immuno-modulatory action of citrus auraptene on macrophage functions and cytokine production of lymp-hocytes in female BALB/c mice [J]. Carcinogen, 1997, 18(11): 2155.
  • 5Murakami A,Kuki W, Takahashi Y, et al. Auraptene, a citrus coumarin, inhibits 12-O-tetradecanoylphorbol-13-acetate- induced tumor promotion in ICR mouse skin, possibly through suppression of superoxide generation in leukocytes[J]. Jpn J Cancer Res, 1997, 88: 443.
  • 6Mori H,Niwa K, Zheng Q, et al. Cell proliferation in cancer prevention: effects of preventive agents on estrogen-related endometrial carcinogenesis model and on an in vitro model in human coloreetal cells[J]. Mut Res, 2001, 480-481: 201.
  • 7Kawabata K,Murakami A, Ohigashi H. Citrus anraptene targets translation of MMP 7(matrilysin) via ERK 1/2-dependent and mTOR-independent mechanism [J]. FEBS Lett, 2006, 580: 5288.
  • 8Kuroyanagi K,Kang MS,Goto T, et al. Citrus auraptene acts as an agonist for PPARs and enhances adiponectin production and MCP-1 reduction in 3T3-L1 adipocytes[J]. Biochem Bio- phys Research Commun, 2008, 366:219.
  • 9Epifano F, Molinaro G, Genovese S, et al. Neuroprotective effect of prenyloxycoumarins from edible vegetables[J]. Neurosci Lett, 2008, 443: 57.
  • 10Stewart BH, Chan OH, Jezyk N, et al. Descrimination between drug candidates using models for evaluation of intestinal absorption[J]. Adv Drug Del Rev, 1997,23 ( 1/2/ 3):27.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部